For liposomal oral tablets, which contain a protective buffer of fatty acids that resist degradation and destruction, researchers recommend a starting dose of 10 mg, but this may be too small of a dose to see positive effects [14, 15]
The target IGF-1 range in most functional-medicine protocols is the upper quartile of age-adjusted reference ranges (roughly 200-300 ng/mL for adults 40-60), not supraphysiological values
ARA-290 works through CD131 receptor activation (the common beta subunit of cytokine receptors), which has zero overlap with GH secretagogue pathways, collagen synthesis routes, or VEGF-mediated angiogenesis
Description Overview IGF-1 LR3 in lyophilized powder form packaged in a sealed glass research vial

How CJC-1295/Ipamorelin Overcomes Age-Related Fat Gain The peptide combination restores growth hormone to more youthful levels, reversing the metabolic decline: Direct Fat-Burning Effects: 24/7 elevated lipolysis continuous fat breakdown, even at rest Preferential visceral fat loss targets dangerous belly fat first Improved nutrient partitioning calories go to muscle, not fat storage Enhanced metabolic rate burn 200-400 more calories daily Muscle-Preserving Effects: Increased protein synthesis build/maintain muscle during caloric deficit Enhanced recovery train harder and more frequently Nitrogen retention prevents muscle catabolism Improved strength lift heavier despite dieting Metabolic Advantages: Better insulin sensitivity improved blood sugar control Increased IGF-1 production anabolic environment despite caloric deficit Enhanced fat oxidation preferentially burn fat for fuel Appetite regulation better control over hunger signals "I feel better, more energetic and I'm losing fat and gaining muscle like I wanted
